Exelixis reported $123.01M in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -43.71M 23.06M
Acceleron Pharma XLRN:US $ -63.66M 0.06M
Agios Pharmaceuticals AGIO:US $ -89.22M 2M
Akebia Therapeutics AKBA:US $ -26.85M 38.09M
Amgen AMGN:US $ 828M 1301M
AstraZeneca AZN:LN 1.13B 768M
Bayer BAYN:GR -2281000000 5.36B
Biomarin Pharmaceutical BMRN:US $ 11.67M 13.41M
Bluebird Bio BLUE:US $ -240.84M 9.63M
Bristol Myers Squibb BMY:US $ 1715M 36M
Cytokinetics CYTK:US $ -54.8M 14.19M
Dicerna Pharmaceuticals DRNA:US $ -40.24M 11.14M
Eisai 4523:JP Y 55407M 61332M
Eli Lilly And LLY:US $ 1403.4M 248.1M
Esperion Therapeutics ESPR:US $ -32533000 50.29M
Exelixis EXEL:US $ 123.01M 127.62M
Genmab GEN:DC 787M 255M
Glaxosmithkline GSK:US $ 1675M 18M
Immunogen IMGN:US $ -27.37M 1.55M
IONIS PHARMACEUT IONS:US $ -81.6M 10.38M
Macrogenics MGNX:US $ -40279000 11.01M
Merk MRK:US $ 1497M 1517M
Mirati Therapeutics MRTX:US $ -164.19M 31.76M
Moderna Inc MRNA:US 3.06B 1.8B
Nektar Therapeutics NKTR:US $ -110.2M 0.81M
Neurocrine Biosciences NBIX:US $ 62.8M 31.3M
Novartis NOVN:VX 3.48B 1.06B
Pfizer PFE:US $ 5914M 397M
Puma Biotechnology PBYI:US $ -1.73M 21.69M
Seattle Genetics SGEN:US $ -89.6M 32.82M
Ultragenyx Pharmaceutical RARE:US $ -82.78M 23.79M
Xencor XNCR:US $ 9.09M 24.76M
YTE INCY:US $ 140.84M 42.04M